Earnings Preview: Bristol Myers Squibb

Bristol Myers Squibb (BMY) is expected to report Q2 earnings before market open Thursday, July 24, with a conference call scheduled for 10:30 am ET.

Guidance

Analysts are expecting a profit of 40c on revenue of $5.09B. The consensus range for EPS is 38c to 42c, with a revenue range of $4.93B to $5.35B, according to First Call. In Q1, Bristol-Myers reported EPS 42c vs. consensus of 41c and revenue $5.18B vs. consensus of $5.12B.

Analyst Views

Possible positive drivers for this quarter include strength in Plavix and Abilify sales, but it remains to be seen if this will offset generic competition for branded drugs. On July 18, Leerink Swann said it expects a solid Q2, beating estimates or in-line. The firm maintained its Market Perform rating on the stock.